- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 68.85M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 69.68M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 74.87M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $5M |
| Stock Repurchased restated | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $913K |
| Capex | Q1 2026 · Mar 31, 2025 | $420K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$13.9M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$19.73M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $176.96M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $199.28M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $313.32M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $340.83M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $396.28M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $410.34M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $44.08M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $39.8M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $65.85M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $62.34M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $240.78M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $261.91M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $379.17M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $403.17M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.32 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.21 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.32 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.21 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $14.56M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $14.1M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $13.65M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $9.6M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$22.38M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$16.04M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$23.27M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$17.75M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $11.8M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $12.3M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $16.12M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $17.63M |
| Revenue | Q1 2026 · Mar 31, 2026 | $27.93M |
| Revenue | Q1 2026 · Mar 31, 2025 | $29.93M |